GRM5 and stroke disorder: We previously reported that pharmacological blockade of mGlu5 (type-5 metabotropic glutamate) receptors improves recovery of sensorimotor function in rodent models of stroke, concomitant with restoration of functional connectivity in the sensorimotor cortex contralateral to the infarct.